Cultivar Capital’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$203K Sell
8,413
-189
-2% -$4.94K 0.13% 40
2026
Q1
$242K Buy
8,602
+201
+2% +$5.35K 0.15% 36
2025
Q4
$209K Buy
+8,401
New +$212K 0.13% 43
2024
Q3
Sell
-5,079
Closed -$142K 140
2024
Q2
$142K Buy
+5,079
New +$140K 0.12% 35

Other funds holding PFE

Cultivar Capital's PFE Position: Q2 2026 in Review

Cultivar Capital reduced its Pfizer (PFE) stake by 2.2% in Q2 2026, selling an estimated $4.94K and leaving 8,413 shares worth $203K. The position accounts for 0.13% of the portfolio, ranked #40.

Cultivar Capital first reported a position in PFE in Q2 2024 and has held it in 4 quarters since. The position peaked at $242K in Q1 2026. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Cultivar Capital held 8,413 shares of Pfizer worth $203K as of Q2 2026.
  • Cultivar Capital sold 189 Pfizer shares in Q2 2026, an estimated $4.94K.
  • Pfizer made up 0.13% of Cultivar Capital's portfolio in Q2 2026, its #40 holding.
  • Cultivar Capital first reported a position in Pfizer in Q2 2024 and has held it in 4 quarters since.
  • Cultivar Capital's Pfizer position peaked at $242K in Q1 2026.
  • 1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Cultivar Capital's 13F filing for Q2 2026, filed 8 Jul 2026.